274 related articles for article (PubMed ID: 29161296)
1. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
Kim GE; Lee JS; Park MH; Yoon JH
PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
Nuzzo PV; Rubagotti A; Zinoli L; Salvi S; Boccardo S; Boccardo F
BMC Cancer; 2016 Feb; 16():95. PubMed ID: 26872609
[TBL] [Abstract][Full Text] [Related]
3. Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion.
Ishiba T; Nagahara M; Nakagawa T; Sato T; Ishikawa T; Uetake H; Sugihara K; Miki Y; Nakanishi A
Sci Rep; 2014 Nov; 4():7069. PubMed ID: 25400079
[TBL] [Abstract][Full Text] [Related]
4. Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma.
Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Witkiewicz W; Dziegiel P
Oncol Rep; 2016 Nov; 36(5):2745-2754. PubMed ID: 27633896
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H
Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
[TBL] [Abstract][Full Text] [Related]
7. Expression of periostin in human breast cancer.
Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
[TBL] [Abstract][Full Text] [Related]
8. Characterization of periostin isoform pattern in non-small cell lung cancer.
Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
10. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer.
Ben QW; Jin XL; Liu J; Cai X; Yuan F; Yuan YZ
Oncol Rep; 2011 Mar; 25(3):709-16. PubMed ID: 21225237
[TBL] [Abstract][Full Text] [Related]
11. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
12. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
[TBL] [Abstract][Full Text] [Related]
13. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer.
Siriwardena BS; Kudo Y; Ogawa I; Kitagawa M; Kitajima S; Hatano H; Tilakaratne WM; Miyauchi M; Takata T
Br J Cancer; 2006 Nov; 95(10):1396-403. PubMed ID: 17060937
[TBL] [Abstract][Full Text] [Related]
14. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
17. Isocitrate dehydrogenase 1-snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability.
Liu WS; Chan SH; Chang HT; Li GC; Tu YT; Tseng HH; Fu TY; Chang HY; Liou HH; Ger LP; Tsai KW
Breast Cancer Res; 2018 Apr; 20(1):25. PubMed ID: 29661250
[TBL] [Abstract][Full Text] [Related]
18. Significance of stromal decorin expression during the progression of breast cancer.
Oda G; Sato T; Ishikawa T; Kawachi H; Nakagawa T; Kuwayama T; Ishiguro M; Iida S; Uetake H; Sugihara K
Oncol Rep; 2012 Dec; 28(6):2003-8. PubMed ID: 22992875
[TBL] [Abstract][Full Text] [Related]
19. Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma.
Cho JS; Park MH; Lee JS; Yoon JH
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):44-53. PubMed ID: 24992172
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
